VR Logo

Laurus Labs Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2005

Chairman: Malempati Venugopala Rao

Managing Director: --

Group: --

Listing: NSE: LAURUSLABS, BSE: 540222

Headquarters: Vishakhapatnam, Andhra Pradesh

Website: www.lauruslabs.com

Key Facts

Market cap: R 17,982.63 Cr

Revenue (TTM): R 3,255.47 Cr

Earnings (TTM): R 411.96 Cr

Cash: R 1.74 Cr

Total Debt: R 1,056.88 Cr

Promoters' ownership: 32.12%

Liquidity: High

52 Week range: R 59.00 - 343.30

Face value: R2.00

Shares outstanding: 53,59,94,995

9 Years Aggregate:

  • CFO: 1,685.08 Cr
  • EBITDA: 2,716.60 Cr
  • Net Profit: 1,117.25 Cr

Stock Performance

Time Period Laurus Labs S&P BSE Healthcare S&P BSE Mid Cap
YTD366.3746.230.06
1 month22.881.335.18
3 months133.5914.398.65
1 Year382.1152.694.03
3 Years45.6111.80-2.48
5 Years--1.476.09
10 Years--11.715.91
As on 23-Oct-2020
Year Laurus Labs S&P BSE Mid Cap S&P BSE Healthcare
2019-6.06-3.05-3.55
2018-29.95-13.31-5.89
201712.9048.130.49

Review & Analysis